We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
Cancer tissues displayed moderate cytoplasmic positivity. Strong staining was observed in a few cases of ovarian, colorectal, testicular, gastric and pancreatic cancers. Additional membranous staining was expressed in colorectal cancers. Lymphomas were weakly stained or negative.
Strong cytoplasmic and occasional membranous positivity was observed in renal cancers and a few cases of melanomas, prostate and liver cancers. Several ovarian, endometrial and pancreatic cancers along with few cases of colorectal, breast, cervical, lung and gastric cancers showed moderate staining. The rest of the tumors were weakly stained or negative.
Cancer tissues displayed moderate cytoplasmic positivity. Additional nuclear staining was observed in testicular cancers. A few cases of pancreatic, renal and liver cancers showed strong staining.
Cancer tissues showed weak to moderate cytoplasmic and membranous staining. Occasional cases of lymphomas and prostate cancers exhibited strong positivity.
GENE INFORMATION
Gene name
BRWD1 (HGNC Symbol)
Synonyms
C21orf107, DCAF19, FLJ11315, N143, WDR9
Description
Bromodomain and WD repeat domain containing 1 (HGNC Symbol)
Entrez gene summary
This gene encodes a member of the WD repeat protein family. WD repeats are minimally conserved regions of approximately 40 amino acids typically bracketed by gly-his and trp-asp (GH-WD) residues which may facilitate formation of heterotrimeric or multiprotein complexes. Members of this family are involved in a variety of cellular processes including cell cycle progression, signal transduction, apoptosis, and gene regulation. This protein contains 2 bromodomains and multiple WD repeats. This gene is located within the Down syndrome region-2 on chromosome 21. Alternative splicing of this gene generates multiple transcript variants encoding distinct isoforms. In mouse, this gene encodes a nuclear protein that has a polyglutamine-containing region that functions as a transcriptional activation domain which may regulate chromatin remodelling and associates with a component of the SWI/SNF chromatin remodelling complex.[provided by RefSeq, Jun 2011]